Literature DB >> 3581635

Clinical pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion.

D Debruyne, B Hurault de Ligny, J P Ryckelynck, F Albessard, M Moulin.   

Abstract

The pharmacokinetics of ketoprofen were evaluated in 29 patients suffering from acute renal colic following a single intravenous administration as a bolus or short infusion (1.5 and 2 hours), and after a loading dose and a 24-hour infusion. Serum concentrations of ketoprofen were measured by high pressure liquid chromatography. The mean (+/- SD) values of clinical parameters were as follows: distribution half-life = 0.34 +/- 0.19 h; elimination half-life = 2.05 +/- 0.58 h; kel = 0.968 +/- 0.282 h-1; k21 = 0.943 +/- 0.425 h-1; k12 = 1.004 +/- 0.708 h-1; volume of central compartment = 5.58 +/- 1.67L; volume of tissue compartment = 5.14 +/- 2.12L; plasma clearance = 5.10 +/- 1.14L/h. These results concur with previously published data obtained after oral or intramuscular administration. According to clinical observations, administration of a ketoprofen bolus suppressed pain within 5 to 30 minutes; the administration of a loading dose and a 24-hour infusion is almost never followed by a recurrence of pain, and this regimen was proposed as the dosage schedule of ketoprofen to treat renal colic.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3581635     DOI: 10.2165/00003088-198712030-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  20 in total

1.  Prostaglandin-synthetase inhibition with diclofenac sodium in treatment of renal colic: comparison with use of a narcotic analgesic.

Authors:  S O Lundstam; K H Leissner; L A Wåhlander; J G Kral
Journal:  Lancet       Date:  1982-05-15       Impact factor: 79.321

2.  Prostaglandins, a link between renal hydro- and hemodynamic in dogs.

Authors:  U B Olsen; M P Magnussen; E Eilertsen
Journal:  Acta Physiol Scand       Date:  1976-07

3.  A double-blind crossover evaluation of ketoprofen (Orudis) and placebo in rheumatoid arthritis with assessment of long-term tolerance.

Authors:  D L Howard
Journal:  J Int Med Res       Date:  1978       Impact factor: 1.671

4.  Antidiuretic hormone levels and the effect of indomethacin on ureteral colic.

Authors:  L Grenabo; M Aurell; K Delin; D Holmlund; J G Sjödin
Journal:  J Urol       Date:  1983-05       Impact factor: 7.450

5.  Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay.

Authors:  R A Upton; R L Williams; T W Guentert; J N Buskin; S Riegelman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Treatment of ureteral colic with intravenous indomethacin.

Authors:  D Holmlund; J G Sjödin
Journal:  J Urol       Date:  1978-12       Impact factor: 7.450

7.  Bioavailability of ketoprofen in man with and without concomitant administration of aluminium phosphate.

Authors:  J L Brazier; J N Tamisier; D Ambert; A Bannier
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

8.  The pharmacokinetics of ketoprofen in man during and after repeated oral dosing (50 mg q.i.d.) with Orudis.

Authors:  O R Lewellen; R Templeton
Journal:  Scand J Rheumatol Suppl       Date:  1976

9.  Pharmacokinetic study of ketoprofen (19.583 R.P.) in man using the tritiated compound.

Authors:  F Delbarre; J C Roucayrol; B Amor; J Ingrand; G Bourat; J Fournel; J Courjaret
Journal:  Scand J Rheumatol Suppl       Date:  1976

10.  [Pharmacological study of ketoprofen (19583RP). Report No. 1. Anti-inflammatory, analgesic and antipyretic activities in oral administration].

Authors:  H Fujimura; K Tsurumi; Y Hiramatsu; K Go; K Nakano
Journal:  Nihon Yakurigaku Zasshi       Date:  1974-07
View more
  9 in total

1.  Prediction of sustained fetal toxicity induced by ketoprofen based on PK/PD analysis using human placental perfusion and rat toxicity data.

Authors:  Shingo Tanaka; Takeshi Kanagawa; Kazuo Momma; Satoko Hori; Hiroki Satoh; Takeshi Nagamatsu; Tomoyuki Fujii; Tadashi Kimura; Yasufumi Sawada
Journal:  Br J Clin Pharmacol       Date:  2017-07-27       Impact factor: 4.335

2.  Percutaneous absorption of ketoprofen from different anatomical sites in man.

Authors:  A K Shah; G Wei; R C Lanman; V O Bhargava; S J Weir
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

3.  Prediction of Tissue-Plasma Partition Coefficients Using Microsomal Partitioning: Incorporation into Physiologically based Pharmacokinetic Models and Steady-State Volume of Distribution Predictions.

Authors:  Kimberly Holt; Min Ye; Swati Nagar; Ken Korzekwa
Journal:  Drug Metab Dispos       Date:  2019-07-19       Impact factor: 3.922

Review 4.  Clinical pharmacokinetics of ketoprofen and its enantiomers.

Authors:  F Jamali; D R Brocks
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

Review 5.  Ketoprofen pharmacokinetics, efficacy, and tolerability in pediatric patients.

Authors:  Hannu Kokki
Journal:  Paediatr Drugs       Date:  2010-10-01       Impact factor: 3.022

6.  Diclofenac and ketoprofen liver toxicity in rat.

Authors:  Zdenko Tomic; Boris Milijasevic; Ana Sabo; Lalosevic Dusan; Vida Jakovljevic; Momir Mikov; Satman Majda; Velibor Vasovic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

7.  Pharmacokinetics of intravenous and rectal ketoprofen in young children.

Authors:  Hannu Kokki; Marko Karvinen; Pekka Suhonen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of ketorolac tromethamine.

Authors:  D R Brocks; F Jamali
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

9.  A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.

Authors:  Min Ye; Swati Nagar; Ken Korzekwa
Journal:  Biopharm Drug Dispos       Date:  2016-04       Impact factor: 1.627

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.